Correction: A β-Lactam Antibiotic Dampens Excitotoxic Inflammatory CNS Damage in a Mouse Model of Multiple Sclerosis

Correction: A β-Lactam Antibiotic Dampens Excitotoxic Inflammatory CNS Damage in a Mouse Model of Multiple Sclerosis

Show other versions (3)

Bibliographic Details
Main Authors:	Nico Melzer, Sven G. Meuth, Delany Torres-Salazar, Stefan Bittner, Alla L. Zozulya, Christian Weidenfeller, Alexandra Kotsiari, Martin Stangel, Christoph Fahlke, Heinz Wiendl
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2008-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2645279/?tool=EBI

Similar Items

A beta-lactam antibiotic dampens excitotoxic inflammatory CNS damage in a mouse model of multiple sclerosis.
by: Nico Melzer, et al.
Published: (2008-09-01)

Correction: A β-Lactam Antibiotic Dampens Excitotoxic Inflammatory CNS Damage in a Mouse Model of Multiple Sclerosis
by: Nico Melzer, et al.
Published: (2011-01-01)

Correction: A β-Lactam Antibiotic Dampens Excitotoxic Inflammatory CNS Damage in a Mouse Model of Multiple Sclerosis.
by: Nico Melzer, et al.
Published: (2011-01-01)

Correction: A β-Lactam Antibiotic Dampens Excitotoxic Inflammatory CNS Damage in a Mouse Model of Multiple Sclerosis.
by: Nico Melzer, et al.
Published: (2008-01-01)

Alemtuzumab in Multiple Sclerosis: Mechanism of Action and Beyond
by: Tobias Ruck, et al.
Published: (2015-07-01)

Primary B Cell Lymphoma of the CNS Mimicking Anti-LGI1 Limbic Encephalitis
by: Christian Thomas, et al.
Published: (2018-08-01)

TRPM2 cation channels modulate T cell effector functions and contribute to autoimmune CNS inflammation.
by: Nico Melzer, et al.
Published: (2012-01-01)

Targeting B cells in relapsing–remitting multiple sclerosis: from pathophysiology to optimal clinical management
by: Stefan Bittner, et al.
Published: (2017-01-01)

Gut–CNS-Axis as Possibility to Modulate Inflammatory Disease Activity—Implications for Multiple Sclerosis
by: Ann-Katrin Fleck, et al.
Published: (2017-07-01)

Therapeutic Apheresis in Acute Relapsing Multiple Sclerosis: Current Evidence and Unmet Needs—A Systematic Review
by: Leoni Rolfes, et al.
Published: (2019-10-01)

Cytotoxic CD8<sup>+</sup> T cells and CD138<sup>+</sup> plasma cells prevail in cerebrospinal fluid in non-paraneoplastic cerebellar ataxia with contactin-associated protein-2 antibodies
by: Melzer Nico, et al.
Published: (2012-07-01)

Early and Degressive Putamen Atrophy in Multiple Sclerosis
by: Julia Krämer, et al.
Published: (2015-09-01)

CD4<sup>+ </sup>CD25<sup>+ </sup>FoxP3<sup>+ </sup>regulatory T cells suppress cytotoxicity of CD8<sup>+ </sup>effector T cells: implications for their capacity to limit inflammatory central nervous system damage at the parenchymal level
by: Göbel Kerstin, et al.
Published: (2012-02-01)

Comparing Plasma Exchange to Escalated Methyl Prednisolone in Refractory Multiple Sclerosis Relapses
by: Steffen Pfeuffer, et al.
Published: (2019-12-01)

A review of therapeutics targeting excitotoxicity in amyotrophic lateral sclerosis
by: Chang, Joshua Sua
Published: (2019)

Generation of a Model to Predict Differentiation and Migration of Lymphocyte Subsets under Homeostatic and CNS Autoinflammatory Conditions
by: Catharina C. Gross, et al.
Published: (2020-03-01)

An endocannabinoid tone limits excitotoxicity in vitro and in a model of multiple sclerosis
by: F. Loría, et al.
Published: (2010-01-01)

The STING-IFN-β-Dependent Axis Is Markedly Low in Patients with Relapsing-Remitting Multiple Sclerosis
by: Lars Masanneck, et al.
Published: (2020-12-01)

Alemtuzumab Improves Cognitive Processing Speed in Active Multiple Sclerosis—A Longitudinal Observational Study
by: Ester Riepl, et al.
Published: (2018-01-01)

Teriflunomide treatment is associated with optic nerve recovery in early multiple sclerosis
by: Steffen Pfeuffer, et al.
Published: (2021-03-01)

Treatment approaches to patients with multiple sclerosis and coexisting autoimmune disorders
by: Tobias Brummer, et al.
Published: (2021-08-01)

Impact of FcγR variants on the response to alemtuzumab in multiple sclerosis
by: Christian W. Keller, et al.
Published: (2019-12-01)

Study of Excitotoxicity
by: Hou, Jen-Dau, et al.
Published: (1997)

The aperiodically dampened loudspeaker system
by: Short, George Elliott III
Published: (2014)

CNS-Targeted Cell Therapy for Multiple Sclerosis
by: Fransson, Moa
Published: (2010)

CNS and cutaneous involvement in tuberous sclerosis complex
by: Fernanda Frotte Bopp Salomon, et al.
Published: (2015-09-01)

The role of the CNS endothelium in the pathogenesis of multiple sclerosis
by: Plumb, Jonathan
Published: (2005)

DAMPening Inflammation by Modulating TLR Signalling
by: A. M. Piccinini, et al.
Published: (2010-01-01)

Apoptosis in retinal excitotoxicity.
Published: (1997)

Advances in Multiple Sclerosis 2017
by: Kerstin Göbel, et al.
Published: (2018-03-01)

Profiling Complement System Components in Primary CNS Vasculitis
by: Milani Deb-Chatterji, et al.
Published: (2021-05-01)

Increased cortical curvature reflects white matter atrophy in individual patients with early multiple sclerosis
by: Michael Deppe, et al.
Published: (2014-01-01)

Generating microglia from human pluripotent stem cells: novel in vitro models for the study of neurodegeneration
by: Anna M. Speicher, et al.
Published: (2019-12-01)

Cortex Parcellation Associated Whole White Matter Parcellation in Individual Subjects
by: Patrick Schiffler, et al.
Published: (2017-07-01)

Neuroprotective function for ramified microglia in hippocampal excitotoxicity
by: Vinet Jonathan, et al.
Published: (2012-01-01)

Targeting ion channels for the treatment of autoimmune neuroinflammation
by: Stefan Bittner, et al.
Published: (2013-09-01)

Identifying the primary site of pathogenesis in amyotrophic lateral sclerosis – vulnerability of lower motor neurons to proximal excitotoxicity
by: Catherine A. Blizzard, et al.
Published: (2015-03-01)

Focusing on caveolin-1 in CNS autoimmune disease: multiple sclerosis
by: Hao Wu, et al.
Published: (2016-01-01)

Listeria monocytogenes dampens the DNA damage response.
by: Ascel Samba-Louaka, et al.
Published: (2014-10-01)

The Agony of Choice? Preserved Affective Decision Making in Early Multiple Sclerosis
by: Nils C. Landmeyer, et al.
Published: (2020-09-01)